Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

UMD Associate Professor Partners with the Dairy Industry to Improve Animal Welfare and Disease Resistance through Genomic Selection


Dairy Cattle, Credit: Edwin Remsberg

Dairy Cattle, Credit: Edwin Remsberg

“If we can use this large dataset to identify genes related to disease resistance, when a producer selects a cow for breeding, they can use information about health and not just focus on milk production. This can create animals that are not only high producers, but also resistant,” says Ma.

With consumer trends moving towards antibiotic-free animal agriculture, selecting for livestock that is disease resistant has become particularly important for animal welfare, as well as for production. To address this need the University of Maryland (UMD) was recently awarded a grant from the United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA) to analyze millions of records maintained by the Council on Dairy Cattle Breeding (CDCB) with the goal of identifying genes and underlying mechanisms for disease resistance in dairy cattle. Mastitis and other cattle diseases not only present a concern for animal welfare, but cost the dairy industry $230 million every year. With this new unique partnership between UMD, the dairy industry, and USDA-NIFA, researchers will be able to capitalize on the wealth of industry data available to make strides in the genetic understanding and ultimate prevention of cattle diseases that haven’t been feasible with smaller datasets.

“With this project, we are generating some knowledge about what genes are related to mastitis and other dairy cattle diseases, as well as providing a model that predicts which animals are more resistant to the disease,” explains, Li Ma, associate professor in Animal & Avian Sciences at UMD and lead investigator on this grant. “If we can use this large dataset to extract health traits and identify genes related to disease resistance, when a producer selects a sire or a cow for breeding, they can use information about health and not just focus on milk production and yield. This can create animals that are not only high producers, but also disease resistant.”

According to Ma and the CDCB, during the last 50 years, milk production from dairy animals in the United States has more than doubled by following traditional breeding paradigms, skyrocketing even more recently with the introduction of genomic selection in 2009. Based on the DNA of dairy cattle, producers have been able to select for animals that will produce the most milk, naturally enhancing breeding practices and greatly improving production in the industry.

“Disease risk has also increased in the same time, however,” says Ma. “That’s why we try now to put more focus on disease resistance with a similar approach, using selection combined with DNA or genetics data to try to improve disease resistance with data already collected from the dairy industry.”

Collaborating with industry through the CDCB with co-investigator Kristian Parker Gaddis is a “win-win” for industry, academia, and future research says Ma. Huge volumes of data have been generated for production purposes, but can be used for much more.

“This big database maintained by CDCB is an industry-supported database where they upload data on the cow’s performance, reproduction, disease records, anything that is important to the value of that cow. They send in a DNA sample to get a sense of the value of the cow, and all of those records – over 2 million cows and 10s of millions of performance records – are maintained in this industry database. Data is already generated by industry and sitting there waiting for analysis. Now that the data is available, we can do more research and application for the industry and for animal welfare.”

Impacts of this work will most directly benefit the dairy industry and welfare of their cattle, explains Ma, as it will help producers select animals that are the most disease resistant. From a research perspective, however, there are many additional opportunities.

“People may also be interested in knowing which genes are related to the disease, which mutations, or which versions of the gene are causing more disease and less disease,” says Ma. “So people may also do some molecular biology functional studies, and this information will help to drive future research. For example, if there is a big genetic target identified from this project, researchers can use genome editing to help cure or correct the disease in question, and inform future research methods or breeding practices. A better understanding of the disease itself and its underlying mechanisms is always important in fighting disease in the long run.”

With this grant, Ma will be looking at dairy cattle diseases as a whole, but with a particular emphasis on mastitis. Mastitis, according to Ma, is the most costly disease for the dairy industry. It is a bacterial infection that causes inflammation in the udder during the milking period and requires antibiotic treatment to heal. A disease like this can only be studied from a genetic perspective with a very large dataset since it is mostly caused by an environmental pathogen, explains Ma.

“Mastitis is caused by a bacterial infection, so it is a very complicated disease to study with genomics. Because it is a complicated disease genetically, you need a large dataset to have the power to see the true signal. Previous genetic studies haven’t had the power because of limited sample sizes. But with this database from industry and millions of records, we are now in a good position to study the genetic component and see how we can help prevent this disease and avoid the use of antibiotics whenever possible.”

Ma adds, “Using a genomics approach, we are trying to enhance the ability of the animal to protect itself from the disease. This will not only reduce the incidence of mastitis, but also the use of antibiotics, so long-term the benefit is higher for the animal’s welfare, from an environmental perspective, and on the production side. This is a win for everybody involved.”

The research team includes Li Ma (principal investigator) and Zhengguo Xiao from Animal & Avian Sciences at UMD, Christian Maltecca from North Carolina State University, Kristen Parker Gaddis from CDCB, Pamela Adkins from the University of Missouri, and John Cole from the Animal Genomics and Improvement Laboratory (AGIL) USDA.

This work is funded by the United States Department of Agriculture National Institute of Food and Agriculture (USDA-NIFA), Award #2020-67015-31398.

Share article on social media or email:

Women’s Health USA Expands into Nevada to Explore and Advance New Care Delivery Models


Women’s Health USA, a leading management services company in the women’s health sector in the United States, announced today a joint venture partnership with Las Vegas-based Women’s Health Associates of Southern Nevada (WHASN), one of the pre-eminent ObGyn groups in Nevada. In this joint venture, Women’s Health USA and WHASN will work together to design and implement value-based delivery care models for a wide range of women’s health services to better serve the health care needs of both Medicaid and commercial patient populations in the Nevada market.

“We are thrilled about this new partnership and the opportunities to partner with WHASN in building a new paradigm of care in women’s health. Nevada has one of the most innovative population health markets in the US and has therefore been a high priority market for Women’s Health USA for some time. Once we identified Nevada as a critical market for us, there was only one choice as to who the right partner was. With WHASN’s market leadership, strong reputation and considerable footprint we have the building blocks to construct a more effective and efficient physician-led, patient-centric, and data-driven women’s health care delivery model,” said Women’s Health USA CEO Goran Dragolovic.

John Martin, M.D., who founded WHASN in 2005 and is a practicing ObGyn within the group, spoke enthusiastically about the partnership and the potential it brings to deepen WHASN’s market presence and influence. “We really wanted a partner that shared the dual vision of leveraging the influence and efficiencies of a large group with the care delivery of small, private setting. After an exhaustive search, Women’s Health USA was the only choice that fit with our long-term growth plan.” Rebecca Herrero, M.D., president for the group added “By working with Women’s Health USA and their bench of experts, we’ll be able to move the ball forward more quickly on some of our key expansion initiatives. Ultimately, our goal is to more deeply reach into our communities of women throughout Nevada and neighboring states to provide the most efficient and effective access to quality, patient-centric care.”

WHASN is a group of over 50 ObGyn physicians and 30 mid-level providers in the Southern Nevada area. The practice has 20 office locations in and around the Las Vegas metro area. The addition of this new partnership expands Women’s Health USA’s footprint as a premier national women’s health services company – now active in 7 states and serving more than 750,000 patients annually.

About Women’s Health USA

With a comprehensive suite of business management services, Women’s Health USA partners with ObGyn, reproductive endocrinology, and other specialty women’s health practices across the United States. It has a 22-year history of implementing creative growth strategies supporting streamlined operational costs, payer alignment, merger and acquisition plans, ancillary services development, marketing, and risk management services. Its unique partnership model enables physicians and physician groups to maintain their independence, while leveraging the resources of a national organization.

About Women’s Health Associates of Southern Nevada

Since 2009, WHASN has been committed to providing high quality healthcare for women in the Southern Nevada area. With 80 providers and 20 locations throughout southern Nevada, each office offers a full range of innovative techniques and technologies to promote and maintain good health practices through all phases of a woman’s life.

Share article on social media or email:

Help.org Names the Best Drug and Alcohol Rehab Centers in Long Beach


News Image

Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Long Beach, California for 2020. The informational guide recognizes the top 16 rehab facilities based on cost, treatment options, location, accompanying services and more.

According to recent studies, drug overdose is the leading cause of death among people under age 50. In Long Beach, deaths related to opioid abuse increased significantly from 2011 to 2015. Substance abuse among adolescents is also escalating in Long Beach with 55 percent of high school students reported using alcohol, 38 percent reported using marijuana, 8 percent reported using prescription drugs without a valid prescription, and 2 percent reported using heroin. With the growing need for accessible and high-quality rehab programs, Help.org has developed a unique ranking process to help connect individuals with treatment providers that meet their needs.

The Help.org research team analyzed thousands of facilities across the country and then identified the most cost-effective and highest rated programs in larger cities like Long Beach. Each facility was evaluated based on rehabilitation services, treatment approaches, cost, special programs for unique demographics and ancillary services. The website also provides information about drug use and side effects as well as educational articles. For a detailed listing of the Best Rehab Facilities in Long Beach, California please visit https://www.help.org/drug-and-alcohol-rehab-centers-in-long-beach-ca

2020 Best Rehab Facilities in Long Beach, California (in alphabetical order)

Tarzana Treatment Centers

2101 Magnolia Avenue Long Beach, CA 90806

562-218-1868

Monarch Shores

27123 Calle Arroyo, Suite 2121 San Juan Capistrano, CA 92675

855-862-5808

Evolve Treatment Centers

820 Moraga Drive Los Angeles, CA 90049

866-204-9519

Tree House Recovery

1901 Newport Boulevard, Suite 271 Costa Mesa, CA 92627

855-202-2138

Exodus Recovery, Inc.

9808 Venice Boulevard, Suite 700 Culver City, CA 90232

310-945-3350

Safe Refuge

1041 East Redondo Avenue Long Beach, CA 90804

562-987-5722

Anaheim Lighthouse

1320 West Pearl Street Anaheim, CA 92801

877-959-5909

New Found Life

2211 East Ocean Boulevard Long Beach, CA 90803

800-635-9899

Sano Center for Recovery

6272 East Pacific Coast Highway, Suite D Long Beach, CA 90803

562-356-9835

Roots Through Recovery

3939 Atlantic Avenue, Suite 102 Long Beach, CA 90807

866-766-8776

Oceanfront Recovery

312 Broadway Street, Suite 202 Laguna Beach CA, 92651

877-279-1777

Ocean Recovery

1115 West Balboa Boulevard Newport Beach, CA 92663

949-942-8495

Hoag Addiction Treatment Newport Beach + Irvine

1 Hoag Drive Newport Beach, CA 92663

888-304-1229

Cambodian Association of America

2390 Pacific Avenue Long Beach, CA 90806

562-988-1863

Salvation Army Long Beach

1370 Alamitos Avenue Long Beach, CA 90813

562-218-2355

ABOUT HELP.ORG

Help.org is an online resource for individuals who struggle with addiction and their loved ones. The website provides the latest research through scientifically proven methods, community recovery resources as well as information about local financial assistance. Help.org’s team of researchers, activists and writers work together with addiction counselors and other professionals to offer useful and accurate resources to help individuals seeking recovery. To learn more, visit https://www.help.org/.

Share article on social media or email:

Makers Nutrition® Wins Grand in the 8th Annual 2020 CEO World Awards


Makers Nutrition® Wins Grand in the 8th Annual 2020 CEO World Awards

This further validates our position as a company poised to successfully overcome the dilemmas caused by COVID-19, as well as common complications faced by private label business owners who often leave their current manufacturers for Makers Nutrition’s unbeatable services.

Makers Nutrition announced today that it now holds a new title: CEO World Awards® Grand Trophy Holder. The CEO World Awards is the world’s top C-level and executive achievement awards program.

CEO World Awards celebrate the achievements of leaders, executives, and their management teams behind the year’s most outstanding initiatives and achievements. Chief Executive Officers, or CEOs, lead the development of their organizations’ short- and long-term strategy. This annual awards program recognizes individuals and teams who set industry benchmarks for excellence. All organizations, private or public, corporations, nonprofits, associations, vendors, and government organizations worldwide are eligible to enter.

Judges from a broad spectrum of global industry voices participated and their average scores determined the 2020 award winners. Winners will be celebrated and presented their awards during a virtual awards ceremony in November.

No stranger to the CEO World Awards, CEO Jason Provenzano is proud to have won multiple gold titles in 2018 and 2019, with 20 titles total for Makers Nutrition. This is the company’s first year winning Grand.

In addition to being named a Grand Trophy winner, Makers Nutrition has garnered the following titles in this year’s CEO World Awards:

  • GOLD – CEO of the Year in Manufacturing
  • GOLD – Entrepreneur of the Year in Healthcare, Pharmaceuticals, Biotech, Health Products & Services
  • GOLD – Entrepreneur of the Year in Manufacturing
  • GOLD – Executive Achievement of the Year in Healthcare, Pharmaceuticals, Biotech, Health Products & Services
  • GOLD – Executive Achievement of the Year in Manufacturing
  • GOLD – Company of the Year in Business Products
  • GOLD – Company of the Year in Business Services
  • GOLD – Company of the Year in Healthcare Products & Services
  • GOLD – Company of the Year in Manufacturing
  • SILVER – CEO Achiever in Business Role Model of the Year
  • SILVER – CEO of the Year in Healthcare, Pharmaceuticals, Biotech, Health Products & Services
  • SILVER – Most Innovative Company of the Year
  • BRONZE – Top CEO of the Year in The Visionary

“It’s an honor to be named a winner by CEO World Awards for this esteemed industry and peer recognition,” said Founder and CEO Jason Provenzano. “This further validates our position as a company poised to successfully overcome the dilemmas caused by COVID-19, as well as common complications faced by private label business owners who often leave their current manufacturers for Makers Nutrition’s unbeatable services. Our clients can attest to the level of customer care provided at all times, and we look forward to continued growth for both Makers Nutrition and our clients.”

For a complete list of the 2020 CEO World Award winners, visit https://ceoworldawards.com/winners/2020-business-awards-winners/.

About the CEO World Awards

CEO World Awards are an annual industry and peer recognition program honoring CEOs, executives, entrepreneurs, innovators and their management teams from organizations in every industry and of every size in Asia, Australia and New Zealand, Canada and the USA, Europe, Mexico, the Caribbean & Central and South America, Middle East and Africa. The Annual CEO World Awards is part of the SVUS Awards® recognition program from Silicon Valley in the United States of America. The coveted annual CEO World Awards program encompasses the world’s best in leadership, innovation, organization performance, new products and services, excellence studies, corporate social responsibility, and milestones from every major industry in the world. Organizations from all over the world are eligible to submit nominations including public and private, for-profit and non-profit, largest to smallest and new start-ups. Learn more about the CEO World Awards at https://ceoworldawards.com.

About the SVUS Awards

SVUS Awards are conferred in eleven programs: the CEO World Awards: the CEO World Awards®, the Consumer World Awards®, the Customer Sales & Service World Wards®, the Globee® Awards, the Golden Bridge Awards®, the Info Security Products Guide’s Global Excellence Awards®, One Planet® American + World Business Awards, the Pillar World Awards®, the PR World Awards® for Public Relations and Communications, and the Women World Awards®. Honoring organizations of all types and sizes and the people behind them, the SVUS Awards recognize outstanding achievements and performances worldwide. Learn more about the SVUS Awards at https://svusawards.com.

About Makers Nutrition

Makers Nutrition, an Inc. 5000 Fastest-Growing Company in America, is a groundbreaking provider for dietary supplement companies worldwide. Specializing in capsules, tablets, powders, softgels and gummies, Makers Nutrition provides a full-service option for all contract manufacturing, graphic design, packaging and fulfillment service needs. Click here to learn more.

Share article on social media or email:

Best Practices, Collaborations and the Future Webinar Sept. 16, 2020


WCG CenterWatch

WCG CenterWatch L

Transforming Global Clinical Trials:

Best Practices, Collaborations and the Future

A CenterWatch/FDAnews Webinar

Wednesday, Sept. 16, 2020, 1:30-3:00 p.m. EDT

https://www.centerwatch.com/transglobalct

It’s a landmark time for clinical trials, with a whirlwind of recent changes that shows no signs of slowing down. From remote monitoring to virtual trials to lessons learned from COVID-19, those involved in conducting clinical trials must transform their operations.

Pamela Tenaerts, MD, MBA, executive director of the Clinical Trials Transformation Initiative (CTTI), a public-private partnership founded by Duke University and the FDA, and CTTI’s co-chair, John H. Alexander, MD, MHS, FACC, will lead this webinar. CTTI —comprised of more than 80 organizations from all sectors of the clinical trials industry — develops and drives the adoption of practices that will increase the quality and efficiency of clinical trials.

They’ll discuss the future of clinical research — one that is patient-centered and easily accessible, integrated with health processes, leverages available data and improves public health — and the critical role of organizational partnerships to achieve quality results in the next generation of clinical trials:

  • Multi-stakeholder perspectives on the future of clinical research
  • Future goals for clinical trials by 2030 using a Quality by Design approach
  • Potential impacts of the COVID-19 pandemic to positively transform clinicalNtrials
  • How organizational collaborative efforts can help advance and enhance the clinical trials landscape
  • Actionable tools and resources available from CTTI that can help organizations and researchers prepare and adapt for future change

If one conducts clinical trials, this presentation is a must.

Interested in registering multiple sites?

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally

to learn about our special multisite discount.

Virtual Conference Details:

Transforming Global Clinical Trials:

Best Practices, Collaborations and the Future

A CenterWatch/FDAnews Webinar

Wednesday, Sept. 16, 2020, 1:30-3:00 p.m. EDT

https://www.centerwatch.com/transglobalct

Tuition:

$287 per site

Easy Ways to Register:

Online: https://www.centerwatch.com/transglobalct

By phone: 888.838.5578 or 703.538.7600

About CenterWatch:

Founded in 1994, CenterWatch is a trusted source and global destination for clinical trials information for both professionals and patients. CenterWatch provides proprietary data and information analysis on clinical trials through a variety of newsletters, books, databases, and information services used by pharmaceutical and biotechnology companies, CROs, SMOs, and investigative sites involved in the management and conduct of clinical trials. As a pioneer in publishing clinical trials information, CenterWatch was the first Internet site to publish detailed information about active clinical trials that could be accessed by patients and their advocates.

Share article on social media or email:

EarthKind® Partners with The Max Cure Foundation for Childhood Cancer Awareness Month


EarthKind® Partners with The Max Cure Foundation

This September, we have partnered with The Max Cure Foundation to offer 20% off of our EarthKind® Stay Away® Starter Pack during Childhood Cancer Prevention Month while donating a portion of our sales to the foundation.

EarthKind® is kicking off September’s Childhood Cancer Awareness Month by asking consumers to support the efforts of The Max Cure Foundation. By partnering with multiple stakeholders, including other CAC2 members, they are bringing attention to the increase in childhood cancer diagnoses. Rates have risen 34% in the United States since 1975, highlighting the need for effective prevention measures.

EarthKind®, an award-winning, plant-based pest prevention brand, manufactures products that effectively keep pests away without killing or poisoning them. Kari Warberg Block, CEO/Founder of EarthKind, announces that, “This September, we have partnered with The Max Cure Foundation to offer 20% off of our EarthKind® Stay Away® Starter Pack during Childhood Cancer Prevention Month while donating a portion of our sales to the foundation. The Max Cure Foundation’s mission is to fund research for the development of pediatric cancer drug therapies including the discovery of less toxic treatments for children with cancer. We at EarthKind wholeheartedly believe in this mission and want to do our part to support non-toxic living and reduce the prevalence of childhood — and all — cancers.”

The EarthKind® approach is entirely different from most pest control brands on the market. With a mission to preserve nature’s delicate ecosystem by creating a world of protection from toxic chemicals, pesticides, and pests for families, farmers, homes and our environment, EarthKind works with nature, not against it, by delivering naturally smarter pest control solutions without the use of hazardous chemicals or poisons. EarthKind’s products are made with plant fibers and essential oils grown on local American family farms.

“Over the past decade, our effective repellents have helped reduce the need for poison/kill pest control methods in the home from 98% to 90%, thereby protecting children and pets from harmful chemical exposure,” remarks Warberg Block.

“Our company is guided by a simple idea: ‘preserve the good, prevent the rest,’ as a conscious company, we believe business has a larger role to play than delivering products or profits,” she remarks, “Brands have to take the lead to make products that do no harm, particularly to our most vulnerable – babies and children. We are proud to support The Max Cure Foundation in their new initiative.”

Use promo code CCSupport20 at checkout on the EarthKind® website to support the cause and receive 20% off your purchase of the EarthKind® Stay Away® Starter Pack. The Stay Away Starter Pack includes one Stay Away® Ants, one Stay Away® Rodent, one Stay Away® Moths, one Stay Away® Spiders, and one bio-based Stay Away® Pouch Pod.

For media inquiries please contact Sara White at sara@adinnyc.com or 914.621.1323.

About EarthKind®

Founded by leading pest prevention expert Kari Warberg Block, EarthKind® is a pioneer in natural prevention for families and households everywhere. EarthKind® is a pest prevention brand that manufactures naturally powerful and effective pest solutions that keep pests away, without killing or poisoning them. All EarthKind® products are designed by inventive artists, scientists and engineers who care about the earth, made in the USA with 80% of the materials sourced from American farms and the company provides handicapped individuals with meaningful employment. Kari was awarded the 2019 GMDC Retail Champions of Change award for her role as an inspirational industry retail leader, and was named to the EY Entrepreneurial Winning Woman Class of 2012, 2013 ND SBA Small Business Person of the Year and National Second Runner Up. Her latest product line, Stay Away® was the winner of the 2015 NEXTY People’s Choice Award for Best New Product of the Year. Learn more at https://www.earthkind.com and on social media:

Facebook: https://www.facebook.com/earthkindinc/

Twitter: https://twitter.com/earthkind

Instagram: @earthkindinc

Pinterest: https://www.pinterest.com/earthkindinc/

YouTube: https://www.youtube.com/user/earthkind2010

Share article on social media or email:



EU-MDR Implementation Virtual Conference, Sept. 29, 2020


WCG FDAnews

WCG FDAnews

EU-Medical Device Regulation and In Vitro Diagnostics Regulation Compliance: Virtual Workshop Series

Presented by FDAnews and Ombu Enterprises

Tuesday, Sept. 29, 2020: EU-MDR Implementation

Tuesday, Oct. 27, 2020: EU-IVDR Implementation

Wednesday, Nov. 4, 2020: Post-Market Activities for the EU-MDR and EU-ICDR

Tuesday, Nov. 10, 2020: Auditing EU-MDR and EU-IVDR Implementation

All sessions are held from 10:00 a.m.-4:30 p.m. ET.

https://www.fdanews.com/eumdrworkshopseries

Join us for one, two, three or four productive days of hands-on virtual training.

The EU-MDR compliance clock is ticking. Legacy products marketed in the EU are at serious risk unless one acts now. Many devicemakers still aren’t ready for May 2021 set date. The transition is one complicated set of rules!

With one extension already granted, any organization selling devices in the region now needs to be ready by the May 2021 set date. There’s little time to spare to get the processes up to par. There is still hope to align manufacturing with these expectations. While it may be impossible to fully meet the EU-MDR or EU-IVDR, learn how to remain compliant.

Mark the calendar for one, two, three, or four productive, exciting days of hands-on sessions with Dan O’Leary, a renowned regulatory and training specialist. Receive detailed checklists on device classifications, the application of Annex I, and internal quality audits, along with a workbook on UDI implementation.

We’ll begin the workshop with a session on EU-MDR Implementation on Tuesday, September 29 from 10:00 a.m. to 4:30 p.m. Attendees will have the opportunity to dig deep into EU-MDR requirements and how a team can move toward full implementation. We’ll cover:


  • Article 120: Transitioning into the EU-MDR through timeline concerns
  • QMS Implementation: Article 10(9) requirements and other QMS elements
  • Device Implementation: Annexes I, II, III, VIII and Article 52
  • Notified Body Interactions: Conformity assessment, notified body technical document review, and notified body on-site audits

Continue with us on Tuesday, October 27, and learn about EU-IVDR Implementation. While the date for these requirements isn’t until May 2022, the time to get started on these changes is now. Join us for this session, and we’ll cover:

  • Article 110: Transitioning into the EU-IVDR through timeline concerns
  • QMS Implementation: Article 10(8) requirements and QMS elements
  • Device Implementation: Annex I, II, III, VIII and Article 48
  • Notified Body Interactions: Conformity assessment, notified body technical document review, and notified body on-site audits

After the knowledge gained from the first two sessions (or if one is already an expert), join us for our third session on Post-Market Activities for the EU-MDR and EU-IVDR on Wednesday, November 4. We’ll discuss:

  • Pre-Market Considerations: Clinical evaluation and performance, risk management and determination, and pre-market indicators and thresholds
  • Market Surveillance: Market and post-market surveillance; clinical follow-up
  • Post-Market Performance Follow-Up and SSCP
  • Vigilance and Trend Analysis

In our fourth and final session, we’ll discuss Auditing EU-MDR and EU-IVDR Implementation on Tuesday, November 10. We’ll share insights on the importance of good project management methods, including those around:

  • Internal Audit Programming: ISO 19011:2018 and 13485:2016
  • Conformity Assessment Paths and Device-Specific Areas: QMS and RMS; Annex I, II, and III
  • Applications to Notifying Bodies
  • Notifying Body Approach to Audits

The deadlines for these new regulations are approaching quickly. Don’t miss this chance to gain expert advice on what can become a complicated, difficult and long process —and do it all from the comfort of one’s own home.

Virtual Conference Details:

EU-Medical Device Regulation and In Vitro Diagnostics Regulation Compliance: Virtual Workshop Series

Presented by FDAnews and Ombu Enterprises

Tuesday, Sept. 29, 2020: EU-MDR Implementation

Tuesday, Oct. 27, 2020: EU-IVDR Implementation

Wednesday, Nov. 4, 2020: Post-Market Activities for the EU-MDR and EU-ICDR

Tuesday, Nov. 10, 2020: Auditing EU-MDR and EU-IVDR Implementation

All sessions are held from 10:00 a.m.-4:30 p.m. ET.

https://www.fdanews.com/eumdrworkshopseries

Tuition:

Part I: $587 per site

Part II: $587 per site

Part III: $587 per site

Part IV: $587 per site

Complete Series: $1,672

Easy Ways to Register:

Online: https://www.fdanews.com/eumdrworkshopseries

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations

Share article on social media or email:

KAMUT® Brand Khorasan Wheat Provides Key Steps to Take for a more Nutritionally-Balanced, Healthier Lifestyle in honor of Healthy Aging Month


KAMUT® Brand Khorasan Wheat can Help Promote Healthy Aging

Results of recent scientific studies have indicated that consumption of organically grown KAMUT® khorasan wheat can help provide protection against a range of chronic health issues such as cardiovascular disease and type 2 diabetes.

Aging is an inevitable process that all human beings will go through in life. Although this natural process is often associated with multiple health challenges, adopting nutritious food habits together with wellness practices can play a key role in supporting healthy aging. Ancient grains like KAMUT® brand khorasan wheat, have survived intact for centuries and are recognized for their nutritional qualities and other attributes that can help maintain good health.

Results of recent scientific studies have indicated that consumption of organically grown KAMUT® khorasan wheat can help provide protection against a range of chronic health issues such as cardiovascular disease and type 2 diabetes.

The United States Census Bureau projects that the number of people age 65 and over will outnumber those under the age of 18 by 2034 for the first time in U.S. history. With many people living longer, making a few simple changes in eating habits can help prevent many chronic diseases. There’s no time like the present to take steps towards a more nutritionally balanced, healthier lifestyle. Here are a few ideas.

1. Increase Fiber Intake: Whether following a specific diet such as Mediterranean, Keto, Vegetarian, Vegan, low carb, or other – eating ancient grains like KAMUT brand wheat, especially as whole grains, can provide the protein, fiber and essential vitamins that modern processed grains can lack. This is especially important for lowering cholesterol, managing blood sugar, and maintaining digestive health.

2. Avoid Vitamin Deficiencies: As we age, we start to lose the capacity to retain and synthetize nutrients. Consuming foods higher in needed nutrients can help combat nutrient deficiencies. KAMUT brand wheat is an excellent source of protein, fiber, zinc, phosphorus, magnesium, vitamin B1 (thiamin), and vitamin B3 (niacin). KAMUT® wheat is also high in minerals such as selenium, copper, manganese, and molybdenum, which among their benefits include contribution to normal cognitive function, normal metabolism, maintaining normal blood pressure, and protection from oxidative stress.

3. Take Care of Your Body: Reducing the consumption of foods that cause inflammation can help prevent health challenges such as arthritis and diabetes. Over a series of scientific studies comparing diets of KAMUT khorasan wheat and other wheat with people suffering from chronic ailments, significant benefits of consumption of KAMUT khorasan wheat were identified for ailments such as cardiovascular disease(1), hypertension(2), diabetes(3), irritable bowel syndrome(4) and non-alcoholic fatty liver syndrome(5). Results consistently highlighted antioxidant and anti-inflammatory properties of KAMUT khorasan wheat and indicated benefits such as lowering of cholesterol (total and LDL cholesterol), managing blood sugar, insulin, and insulin resistance, while increasing antioxidant capacity, and concentration of some minerals such as magnesium, and potassium in the blood. The most notable finding was the indication of a decrease of inflammation markers after consumption of a diet of KAMUT khorasan wheat.

And if all these amazing health benefits weren’t enough, KAMUT khorasan wheat tastes great! Its natural buttery and nutty flavor make it a favorite of bakers, pasta makers, chefs, and home cooks the world over.

To find more information about KAMUT® khorasan wheat and health studies conducted on KAMUT® khorasan wheat, please visit Kamut.com.

About KAMUT® Brand Khorasan Wheat

From 36 kernels and legends of discovery in Egyptian tombs, today KAMUT® brand khorasan wheat, an ancient grain, guaranteed under the KAMUT® brand, to never be hybridized or genetically modified, always organically grown, prized for its nutrition, ease of digestibility, sweet nutty-buttery taste and firm texture, can be found throughout the world in products including breads, pasta, pizza, cereals, snacks, pastries, crackers, beer, green foods, and cereal drinks.

Media please contact Giselle Chollett: giselle@adinnyc.com, 917.386.7116.

Cited Studies

1. Whittaker A. et al. 2015. An Organic Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients with Acute Coronary Syndrome: A Randomized Crossover Trial. Nutrients. 7(5):3401-15.

2. Cicero A.F.G. et al. 2018. Short-Term Hemodynamic Effects of Modern Wheat Products Substitution in Diet with Ancient Wheat Products: A Cross-Over, Randomized Clinical Trial. Nutrients. 10(11):1666.

3. Whittaker A. et al. 2017. A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial. European Journal of Nutrition. 56(3):1191-1200.

4. Sofi F. et al. 2014. Effect of Triticum turgidum subsp. turanicum wheat on irritable bowel syndrome: a double-blinded randomised dietary intervention trial. British Journal of Nutrition. 111(11):1992-9.

5. Dinu M. et al. 2018. A Khorasan Wheat-Based Replacement Diet Improves Risk Profile of Patients With Nonalcoholic Fatty Liver Disease (NAFLD): A Randomized Clinical Trial. Journal of the American College of Nutrition. 37(6):508-514.

Share article on social media or email:

Carrie L. Hall Named to New York Life’s Chairman’s Cabinet


“After 32 years in the business, I’m humbled to be recognized during such a monumental year in New York Life’s history,” Hall said.

Carrie L. Hall has been named a member of the 2020 Chairman’s Cabinet of New York Life today. The Chairman’s Cabinet is made up of the top 50 members of the Chairman’s Council, of whom ranks in the top three percent of New York Life’s elite field force of more than 12,000 licensed agents in sales achievement.

Mrs. Hall has been a New York Life agent since 1988 and is associated with New York Life’s Arizona General Office in Phoenix. This year marks New York Life’s 175th year of exceptional insurance and financial service.

“After 32 years in the business, I’m humbled to be recognized during such a monumental year in New York Life’s history,” Hall said.

She is a member of the board of directors for New York Life Agent Reinsurance Company (NYLARC). She is a Top of the Table Member of the Million Dollar Round Table (MDRT) and was elected to serve for four years on the Board of Directors for The Nautilus Group® in 2018. The Nautilus Group® is an exclusive, advanced planning resource for estate conservation and business continuation strategies and is a service of New York Life Insurance Company. She holds the Chartered Life Underwriter (CLU®) and Certified Financial Planner® (CFP®) designations from the American College and graduated cum laude from Arizona State University.

Hall is actively involved in her community, serving on several boards and actively contributing to organizations such as Valley Estate Planners, Advanced Life Underwriters Association (AALU), Women’s Board of the Barrow Neurological Institute, Arizona Women’s Board Supporting Kidney Health, The Brophy Foundation, and Arizona Community Foundation Professional Advisory Board.

Bates 1869600

Share article on social media or email: